| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22f78ac486adee4534dc1c3a59f5de0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 |
| filingDate |
2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fd39729d4386965d5ac53a48c549e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e4edf91c0cf6afd06877a22f99915e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98c9ebef0a7fd27039b70eb7f021dfe6 |
| publicationDate |
2020-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2778524-T3 |
| titleOfInvention |
Mutual prodrug comprising short chain fatty acids and zebularin or 1'-cyano-cytarabine for the treatment of cancer |
| abstract |
A mutual prodrug compound consisting of a zebularin nucleoside represented by formula (I) or 1'-cyano-cytarabine represented by formula (II) covalently linked to one or more short chain fatty acids (SCFA), wherein the SCFAs are selected from the group consisting of butyric acid and isobutyric acid and SCFAs are attached at the 5 'position or the 2', 3 'and 5' positions of the nucleoside of formula (I) or (II): ** ( See formula) ** |
| priorityDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |